LVTX
NASDAQ
NL
LAVA Therapeutics N.V. - Ordinary Shares
$1.74
+0.0 (+0.0%)
5
Quality Score
fail
Rev ✗
NI ✗
>IPO ✗
Mkt Cap
$45.8M
ROE
-71.0%
Margin
-135.3%
D/E
0.00
Beta
0.26
52W
$1–$2
Wall Street Consensus
7 analysts · Mar 20260
Strong Buy
0
Buy
4
Hold
1
Sell
2
Strong Sell
0.0%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 50.0%
Next Report
May 12, 2026
EPS Estimate: $-0.21
| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Mar 2026 | $-0.21 | — | — |
| Sep 2025 | $-0.25 | $-0.27 | $-0.02 |
| Jun 2025 | $-0.26 | $-0.32 | $-0.06 |
| Mar 2025 | $-0.39 | $-0.13 | +$0.26 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | — | -71.0% | -71.0% | -71.0% | -71.0% | -71.0% |
| P/E (TTM) | — | — | — | — | — | — |
| Net Margin | — | -135.3% | -135.3% | -135.3% | -135.3% | -135.3% |
| Gross Margin | — | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| D/E Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 10.78 | 6.73 | 10.78 | 10.78 | 10.78 | 10.78 |
Key Ratios
ROA (TTM)
-29.3%
P/S (TTM)
2.41
P/B
0.9
EPS (TTM)
$-1.83
CF/Share
$-1.55
Rev Growth 3Y
+33.8%
52W High
$1.83
52W Low
$0.85
$0.85
52-Week Range
$1.83
How does LVTX compare to Biotechnology peers?
Peer group: Micro-cap Biotechnology (All) · 528 companies
LVTX valuation vs Biotechnology peers
P/E ratio
—
▼
0%
below
peers
(18.8)
vs Peers
vs Industry
Undervalued
P/S ratio
2.4
▼
81%
below
peers
(12.9)
vs Peers
vs Industry
Undervalued
P/B ratio
0.9
▼
64%
below
peers
(2.5)
vs Peers
vs Industry
Undervalued
Div yield
—
▼
0%
below
peers
(0.0%)
vs Peers
vs Industry
Low yield
LVTX profitability vs Biotechnology peers
ROE
-71.0%
▼
6%
below
peers
(-67.3%)
vs Peers
vs Industry
In line
Net margin
-135.3%
▲
53%
above
peers
(-286.8%)
vs Peers
vs Industry
Below avg
Gross margin
100.0%
▲
27%
above
peers
(78.6%)
vs Peers
vs Industry
Weak
ROA
-29.3%
▲
37%
above
peers
(-46.7%)
vs Peers
vs Industry
Below avg
LVTX financial health vs Biotechnology peers
D/E ratio
0.0
▼
0%
below
peers
(0.0)
vs Peers
vs Industry
Low debt
Current ratio
10.8
▲
143%
above
peers
(4.4)
vs Peers
vs Industry
Strong liquidity
Beta
0.3
▼
73%
below
peers
(1.0)
vs Peers
vs Industry
More volatile
LVTX fundamentals radar
LVTX
Peer median
Industry
LVTX profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
LVTX vs peers: key metrics
Latest News
No related news yet